imatinib

Twenty-five years after imatinib transformed chronic myeloid leukaemia from a fatal diagnosis into a manageable disease for many patients, Brian Druker reflects on the curiosity, setbacks, and patients who shaped one of oncology's greatest breakthroughs. Long before I understood the…

We often describe progress in oncology through the language of innovation. New drugs. New technologies. New discoveries. Yet scientific breakthroughs rarely change cancer care on their own. They require people willing to pursue difficult ideas, build institutions, challenge accepted thinking,…

Advances in leukaemia treatment have accelerated from first-generation chemotherapy to precision targets and cellular immunotherapy. In this article, we summarise a paper by Robert Peter Gale, published in the OncoDaily Medical Journal, tracing that evolution across ALL, AML, CLL, and…

Following doctor’s orders doesn’t usually mean making a two-hour round trip to visit your hospital twice a week to beg for any spare medication on the off-chance that someone has had to change to a different drug, or was able…